Can the MRI signal of aggressive fibromatosis be used to predict its behavior?

European Journal of Radiology

Volumn 69, Issue 2, 2009, Pages 222-229

  Castellazzi, G ^a,c   Vanel, D ^b,c   Le Cesne, A ^c   Le Pechoux, C ^c   Caillet, H ^c   Perona, F ^a   Bonvalot, S ^c  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Aggressive Fibromatosis; MRI; Signal; Therapy

Indexed keywords

AGGRESSIVE FIBROMATOSIS; BEHAVIOR-BASED; CONTRAST MEDIUMS; DRUG ADMINISTRATIONS; HIGH RATES; IN-BETWEEN; MEDICAL TREATMENTS; MR IMAGING; MR SIGNALS; MRI; NEW STUDIES; RADIATION THERAPIES; SIGNAL; SIGNAL CHANGES; SIGNAL FEATURES; SIGNAL STABILITIES; SOFT TISSUES; THERAPY;

CONTRAST MEDIA; RADIOTHERAPY; SURGERY; TUMORS;

SIGNAL SYSTEMS;

CONTRAST MEDIUM; IMATINIB; TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROMATOSIS; HUMAN; INJECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 59649119133     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.10.012     Document Type: Article

References (21)

1. Hosalkar H.S., Fox E.J., Delaney T., Torbert J.T., Ogilvie C.M., and Lackman R.D. Desmoid tumors and current status of management. Orthop Clin North Am 37 1 (2006) 53-63
2. Tanaka H., Harasawa A., and Furui S. Usefulness of MR Imaging in assessment of tumor extent of aggressive fibromatosis. Radiat Med 23 2 (2005) 111-115
3. Padhani A.R., and Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol 74 887 (2001) 983-986
4. Vanel D., Ubaldino V., Coffre C., Genin J., Contesso G., and Sarrazin D. The value of magnetic resonance imaging in the surveillance of fibromatosis. A study of 10 cases. J Radiol 70 1 (1989) 33-36
5. Duggal A., Dickinson I.C., Sommerville S., and Gallie P. The management of extra-abdominal desmoid tumours. Int Orthop 28 4 (2004) 252-256
6. Vandevenne J.E., De Schepper A.M., De Beuckeleer L., et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol 7 7 (1997) 1013-1019
7. Lee J.C., Thomas J.M., Phillips S., Fisher C., and Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR 186 1 (2006) 247-254
8. Robbin M.R., Murphey M.D., Temple H.T., Kransdorf M.J., and Choi J.J. Imaging of musculoskeletal fibromatosis. Radiographics 21 3 (2001) 585-600
9. Feld R., Burk Jr. D.L., McCue P., Mitchell D.G., Lackman R., and Rifkin M.D. MRI of aggressive fibromatosis: frequent appearance of high signal intensity on T2-weighted images. Magn Reson Imaging 8 5 (1990) 583-588
10. Bloem J.L. Imaging of soft tissue tumors. J Belg Radiol 75 4 (1992) 265-273
11. Hartman T.E., Berquist T.H., and Fetsch J.F. MR imaging of extraabdominal desmoids: differentiation from other neoplasms. AJR 158 3 (1992) 581-585
12. Quinn S.F., Erickson S.J., Dee P.M., et al. MR imaging in fibromatosis: results in 26 patients with pathologic correlation. AJR 156 3 (1991) 539-542
13. van Kints M.J., Tjon A., Tham R.T., Vroegindeweij D., and van Erp A.J. Magnetic resonance imaging findings in aggressive fibromatosis. Eur J Radiol 16 3 (1993) 230-232
14. Burke A.P., Sobin L.H., Shekitka K.M., Federspiel B.H., and Helwig E.B. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 14 4 (1990) 335-341
15. Baerg J., Murphy J.J., and Magee J.F. Fibromatoses: clinical and pathological features suggestive of recurrence. J Pediatr Surg 34 7 (1999) 1112-1114
16. Skene A.I., Barr L., A'Hern R.P., Fisher C., and Meirion Thomas J. Multimodality treatment in the control of deep musculoaponeurotic fibromatosis. Br J Surg 85 5 (1998) 655-658
17. Miralbell R., Suit H.D., Mankin H.J., Zuckerberg L.R., Stracher M.A., and Rosenberg A.E. Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 18 3 (1990) 535-540
18. Nuyttens J.J., Rust P.F., Thomas Jr. C.R., and Turrisi III A.T. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 88 7 (2000) 1517-1523
19. Bernard J., Le Breton C., Piriou P., et al. Value of MRI to evaluate extra-abdominal desmoid fibromatosis. J Radiol 83 6 Pt 1 (2002) 711-716
20. Bonvalot S., Eldweny H., Haddad V., et al. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 34 4 (2008) 462-468
21. Spear M.A., Jennings L.C., Mankin H.J., et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40 3 (1998) 637-645